9 Meters Biopharma Statistics Share Statistics 9 Meters Biopharma has 14.46M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 14.46M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 12.75M Failed to Deliver (FTD) Shares 730 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 580.63K, so 4.02% of the outstanding
shares have been sold short.
Short Interest 580.63K Short % of Shares Out 4.02% Short % of Float 4.08% Short Ratio (days to cover) 16.57
Valuation Ratios The PE ratio is -0.36 and the forward
PE ratio is null.
9 Meters Biopharma's PEG ratio is
-0.02.
PE Ratio -0.36 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 6.8 P/FCF Ratio -0.44 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation 9 Meters Biopharma has an Enterprise Value (EV) of 23.41M.
EV / Sales 0 EV / EBITDA -0.56 EV / EBIT -0.63 EV / FCF -0.63
Financial Position The company has a current ratio of 1.08,
with a Debt / Equity ratio of 8.22.
Current Ratio 1.08 Quick Ratio 1.08 Debt / Equity 8.22 Debt / EBITDA -0.48 Debt / FCF -0.53 Interest Coverage -15.75
Financial Efficiency Return on Equity is -1896.06% and Return on Invested Capital is -197.45%.
Return on Equity -1896.06% Return on Assets -137.31% Return on Invested Capital -197.45% Revenue Per Employee n/a Profits Per Employee $-4.55M Employee Count 10 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.75M Effective Tax Rate -4%
Stock Price Statistics The stock price has increased by 314.2% in the
last 52 weeks. The beta is 1.48, so 9 Meters Biopharma's
price volatility has been higher than the market average.
Beta 1.48 52-Week Price Change 314.2% 50-Day Moving Average 0.51 200-Day Moving Average 1.37 Relative Strength Index (RSI) 8.52 Average Volume (20 Days) 446,108
Income Statement
Revenue n/a Gross Profit n/a Operating Income -42.02M Net Income -45.52M EBITDA -41.51M EBIT -41.1M Earnings Per Share (EPS) -3.51
Full Income Statement Balance Sheet The company has 12.65M in cash and 19.73M in
debt, giving a net cash position of -7.08M.
Cash & Cash Equivalents 12.65M Total Debt 19.73M Net Cash -7.08M Retained Earnings -212.61M Total Assets 9.31M Working Capital -6.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -37.24M
and capital expenditures -2.84K, giving a free cash flow of -37.25M.
Operating Cash Flow -37.24M Capital Expenditures -2.84K Free Cash Flow -37.25M FCF Per Share -2.87
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NMTR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield -278.83% FCF Yield -228.17%
Dividend Details Analyst Forecast Currently there are no analyst rating for NMTR.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 18, 2022. It was a
backward
split with a ratio of 1:20.
Last Split Date Oct 18, 2022 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -50.22 Piotroski F-Score 2
